DESCRIPTION OF THE REAL-WORLD TREATMENT PATTERNS OF GUSELKUMAB IN THE MANAGEMENT OF PSORIATIC ARTHRITIS IN AUSTRALIA: AN ANALYSIS FROM THE OPAL DATASET

被引：0
|
作者：
Littlejohn, G. [1 ,2 ]
Anbumurali, N. [1 ]
Bird, P. [1 ,3 ,4 ]
Youssef, P. [1 ,5 ,6 ]
Osullivan, C. [1 ]
Smith, T. [1 ]
Sumpton, D. [1 ,5 ,7 ]
Kane, B. [1 ,7 ]
Mcgeachie, A. [8 ]
Spiers, S. [9 ]
Deakin, C. [1 ]
机构：
[1] OPAL Rheumatol Ltd, Rheumatol, Sydney, NSW, Australia
[2] Monash Univ, Dept Med, Clayton, Australia
[3] Univ New South Wales, Sch Clin Med, Kensington, Australia
[4] Emeritus Res, Rheumatol, Botany, Australia
[5] Univ Sydney, Dept Med, Sydney, Australia
[6] Royal Prince Alfred Hosp, Dept Rheumatol, Camperdown, Australia
[7] Concord Repatriat Gen Hosp, Dept Rheumatol, Concord, Australia
[8] Janssen, Outcomes Res, Macquarie, Australia
[9] Janssen, Med Affairs, Macquarie, Australia
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Real-world evidence; Psoriatic arthritis; bDMARD;
D O I：
10.1136/annrheumdis-2023-eular.3359
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB1112
引用
收藏
页码：1785 / 1785
页数：1
相关论文
共 50 条
  • [31] Effectiveness of risankizumab for the treatment of psoriatic arthritis: a multicenter, real-world study
    Graceffa, Dario
    Zangrilli, Arianna
    Caldarola, Giacomo
    Lora, Viviana
    Orsini, Diego
    Moretta, Gala
    Pagnanelli, Gianluca
    Provini, Alessia
    Masini, Cinzia
    Bavetta, Mauro
    Giordano, Domenico
    Richetta, Antonio
    Tolino, Ersilla
    Bianchi, Luca
    Peris, Ketty
    Sperati, Francesca
    Bonifati, Claudio
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2024,
  • [32] Six-Month Persistence and Multi-domain Effectiveness of Guselkumab in Adults with Psoriatic Arthritis: Real-World Data from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry
    Mease, Philip J.
    Ogdie, Alexis
    Tesser, John
    Shiff, Natalie J.
    Lin, Iris
    Chakravarty, Soumya D.
    Kelleman, Michael
    Dodge, Rhiannon
    McLean, Robert R.
    Broadwell, Aaron
    Kavanaugh, Arthur
    Merola, Joseph F.
    RHEUMATOLOGY AND THERAPY, 2023, 10 (06) : 1479 - 1501
  • [33] Real-world effectiveness and persistence of secukinumab in the treatment of patients with psoriatic arthritis
    Alegre-Sancho, Juan Jose
    Nunez-Monje, Victoria
    Campos-Fernandez, Cristina
    Balaguer-Trull, Isabel
    Robustillo-Villarino, Montserrat
    Aguilar-Zamora, Marta
    Garijo-Bufort, Marta
    Pedraz-Penalva, Teresa
    Pena-Gonzalez, Carolina
    de la Morena, Isabel
    Bedoya-Sanchis, Diego
    Yankova-Komsalova, Liliya
    Conesa-Mateos, Arantxa
    Martinez-Cristobal, Anna
    Navarro-Blasco, Francisco Javier
    Senabre-Gallego, Jose Miguel
    Sivera, Francisca
    FRONTIERS IN MEDICINE, 2023, 10
  • [34] REAL-WORLD PATIENT EXPERIENCE AND TREATMENT PREFERENCES IN PATIENTS WITH PSORIATIC ARTHRITIS
    Ogdie, A.
    Mansfield, C.
    Myers, K.
    Tillett, W.
    Nash, P.
    Leach, C.
    Nowell, W. B.
    Gavigan, K.
    Zueger, P.
    Mcdearmon-Blondell, E.
    Walsh, J. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 237 - 238
  • [35] Real-World Treatment Patterns and Healthcare Costs in Patients with Psoriatic Arthritis Treated with Ixekizumab: A Retrospective Study
    Murage, Mwangi J.
    Princic, Nicole
    Park, Julie
    Malatestinic, William
    Zhu, Baojin
    Atiya, Bilal
    Kern, Scott A.
    Stenger, Keri B.
    Sprabery, Aubrey Trevelin
    Ogdie, Alexis
    ACR OPEN RHEUMATOLOGY, 2021, 3 (12) : 879 - 887
  • [36] Real-world evaluation of effectiveness, persistence, and usage patterns of tofacitinib in treatment of rheumatoid arthritis in Australia
    Bird, Paul
    Littlejohn, Geoffrey
    Butcher, Belinda
    Smith, Tegan
    Pereira, Candida da Fonseca
    Witcombe, David
    Griffiths, Hedley
    CLINICAL RHEUMATOLOGY, 2020, 39 (09) : 2545 - 2551
  • [37] Real-world evaluation of effectiveness, persistence, and usage patterns of tofacitinib in treatment of rheumatoid arthritis in Australia
    Paul Bird
    Geoffrey Littlejohn
    Belinda Butcher
    Tegan Smith
    Candida da Fonseca Pereira
    David Witcombe
    Hedley Griffiths
    Clinical Rheumatology, 2020, 39 : 2545 - 2551
  • [38] Improvements in Patient-Reported Outcomes Through 6 Months of Guselkumab Treatment in Patients with Active Psoriatic Arthritis: Real-World Data from the CorEvitas Psoriatic Arthritis/Spondyloarthritis (PsA/SpA) Registry
    Mease, Philip J.
    Ogdie, Alexis R.
    Tesser, John
    Shiff, Natalie
    Lin, Iris
    Chakravarty, Soumya
    Kelleman, Mike
    Dodge, Rhiannon
    McLean, Robert
    Broadwell, Aaron
    Kavanaugh, Arthur
    Merola, Joseph F.
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 2767 - 2770
  • [39] Treatment patterns with etanercept and adalimumab for psoriatic diseases in a real-world setting
    Bonafede, Machaon
    Johnson, Barbara H.
    Fox, Kathleen M.
    Watson, Crystal
    Gandra, Shravanthi R.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2013, 24 (05) : 369 - 373
  • [40] Ustekinumab in psoriatic arthritis: need for studies from real-world evidence
    Queiro, Ruben
    Coto-Segura, Pablo
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2018, 18 (09) : 931 - 935
12345